IBDEI077 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9423,1,3,0)
 ;;=3^Chorioretinitis
 ;;^UTILITY(U,$J,358.3,9423,1,4,0)
 ;;=4^363.20
 ;;^UTILITY(U,$J,358.3,9423,2)
 ;;=Chorioretinitis^23913
 ;;^UTILITY(U,$J,358.3,9424,0)
 ;;=115.92^^63^613^43
 ;;^UTILITY(U,$J,358.3,9424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9424,1,3,0)
 ;;=3^Histoplamosis (Pohs)
 ;;^UTILITY(U,$J,358.3,9424,1,4,0)
 ;;=4^115.92
 ;;^UTILITY(U,$J,358.3,9424,2)
 ;;=Histoplamosis Retinitis^266905
 ;;^UTILITY(U,$J,358.3,9425,0)
 ;;=363.70^^63^613^15
 ;;^UTILITY(U,$J,358.3,9425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9425,1,3,0)
 ;;=3^Choroidal Detachment
 ;;^UTILITY(U,$J,358.3,9425,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,9425,2)
 ;;=Choroidal Detachment^276841
 ;;^UTILITY(U,$J,358.3,9426,0)
 ;;=363.63^^63^613^19
 ;;^UTILITY(U,$J,358.3,9426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9426,1,3,0)
 ;;=3^Choroidal Rupture
 ;;^UTILITY(U,$J,358.3,9426,1,4,0)
 ;;=4^363.63
 ;;^UTILITY(U,$J,358.3,9426,2)
 ;;=Choroidal Rupture^268698
 ;;^UTILITY(U,$J,358.3,9427,0)
 ;;=379.22^^63^613^5
 ;;^UTILITY(U,$J,358.3,9427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9427,1,3,0)
 ;;=3^Asteroid Hyalosis
 ;;^UTILITY(U,$J,358.3,9427,1,4,0)
 ;;=4^379.22
 ;;^UTILITY(U,$J,358.3,9427,2)
 ;;=Asteroid Hyalosis^269310
 ;;^UTILITY(U,$J,358.3,9428,0)
 ;;=379.21^^63^613^104
 ;;^UTILITY(U,$J,358.3,9428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9428,1,3,0)
 ;;=3^Vitreous Detachment/Degeneration (Pvd)
 ;;^UTILITY(U,$J,358.3,9428,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,9428,2)
 ;;=Vitreous Detachment/Degeneration^88242
 ;;^UTILITY(U,$J,358.3,9429,0)
 ;;=379.24^^63^613^105
 ;;^UTILITY(U,$J,358.3,9429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9429,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,9429,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,9429,2)
 ;;=Vitreous Floaters^88242
 ;;^UTILITY(U,$J,358.3,9430,0)
 ;;=379.26^^63^613^107
 ;;^UTILITY(U,$J,358.3,9430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9430,1,3,0)
 ;;=3^Vitreous Prolapse
 ;;^UTILITY(U,$J,358.3,9430,1,4,0)
 ;;=4^379.26
 ;;^UTILITY(U,$J,358.3,9430,2)
 ;;=Vitreous Prolapse^269312
 ;;^UTILITY(U,$J,358.3,9431,0)
 ;;=379.23^^63^613^106
 ;;^UTILITY(U,$J,358.3,9431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9431,1,3,0)
 ;;=3^Vitreous Hemorrhage
 ;;^UTILITY(U,$J,358.3,9431,1,4,0)
 ;;=4^379.23
 ;;^UTILITY(U,$J,358.3,9431,2)
 ;;=Vitreous Hemorrhage^127096
 ;;^UTILITY(U,$J,358.3,9432,0)
 ;;=362.18^^63^613^89
 ;;^UTILITY(U,$J,358.3,9432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9432,1,3,0)
 ;;=3^Retinal Vasculitis
 ;;^UTILITY(U,$J,358.3,9432,1,4,0)
 ;;=4^362.18
 ;;^UTILITY(U,$J,358.3,9432,2)
 ;;=Retinal Vasculitis^264463
 ;;^UTILITY(U,$J,358.3,9433,0)
 ;;=360.21^^63^613^31
 ;;^UTILITY(U,$J,358.3,9433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9433,1,3,0)
 ;;=3^Degenerative Myopia
 ;;^UTILITY(U,$J,358.3,9433,1,4,0)
 ;;=4^360.21
 ;;^UTILITY(U,$J,358.3,9433,2)
 ;;=Degenerative Myopia^268553
 ;;^UTILITY(U,$J,358.3,9434,0)
 ;;=362.64^^63^613^80
 ;;^UTILITY(U,$J,358.3,9434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9434,1,3,0)
 ;;=3^Reticular Degeneration
 ;;^UTILITY(U,$J,358.3,9434,1,4,0)
 ;;=4^362.64
 ;;^UTILITY(U,$J,358.3,9434,2)
 ;;=Reticular Degeneration^268645
 ;;^UTILITY(U,$J,358.3,9435,0)
 ;;=362.61^^63^613^29
 ;;^UTILITY(U,$J,358.3,9435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9435,1,3,0)
 ;;=3^Degeneration, Paving Stone
 ;;^UTILITY(U,$J,358.3,9435,1,4,0)
 ;;=4^362.61
 ;;^UTILITY(U,$J,358.3,9435,2)
 ;;=Paving Stone Degeneration^268642
 ;;^UTILITY(U,$J,358.3,9436,0)
 ;;=362.42^^63^613^94
 ;;^UTILITY(U,$J,358.3,9436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9436,1,3,0)
 ;;=3^Rpe Detachment, Serous
 ;;^UTILITY(U,$J,358.3,9436,1,4,0)
 ;;=4^362.42
 ;;^UTILITY(U,$J,358.3,9436,2)
 ;;=Serous RPE Detachment^268633
 ;;^UTILITY(U,$J,358.3,9437,0)
 ;;=362.43^^63^613^93
 ;;^UTILITY(U,$J,358.3,9437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9437,1,3,0)
 ;;=3^Rpe Detachment, Hemorrhagic
 ;;^UTILITY(U,$J,358.3,9437,1,4,0)
 ;;=4^362.43
 ;;^UTILITY(U,$J,358.3,9437,2)
 ;;=Hemorrhagic RPE Detachment^268634
 ;;^UTILITY(U,$J,358.3,9438,0)
 ;;=250.00^^63^613^34
 ;;^UTILITY(U,$J,358.3,9438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9438,1,3,0)
 ;;=3^Dm Type II, No Retinopathy
 ;;^UTILITY(U,$J,358.3,9438,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,9438,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,9439,0)
 ;;=250.01^^63^613^33
 ;;^UTILITY(U,$J,358.3,9439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9439,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,9439,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,9439,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,9440,0)
 ;;=250.50^^63^613^25
 ;;^UTILITY(U,$J,358.3,9440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9440,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,9440,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,9440,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,9441,0)
 ;;=250.51^^63^613^27
 ;;^UTILITY(U,$J,358.3,9441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9441,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,9441,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,9441,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,9442,0)
 ;;=362.01^^63^613^32
 ;;^UTILITY(U,$J,358.3,9442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9442,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,9442,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,9442,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,9443,0)
 ;;=362.02^^63^613^72
 ;;^UTILITY(U,$J,358.3,9443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9443,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,9443,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,9443,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,9444,0)
 ;;=362.03^^63^613^64
 ;;^UTILITY(U,$J,358.3,9444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9444,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,9444,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,9444,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,9445,0)
 ;;=362.04^^63^613^61
 ;;^UTILITY(U,$J,358.3,9445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9445,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,9445,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,9445,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,9446,0)
 ;;=362.05^^63^613^62
 ;;^UTILITY(U,$J,358.3,9446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9446,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,9446,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,9446,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,9447,0)
 ;;=362.06^^63^613^98
 ;;^UTILITY(U,$J,358.3,9447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9447,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,9447,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,9447,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,9448,0)
 ;;=379.27^^63^613^103
 ;;^UTILITY(U,$J,358.3,9448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9448,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,9448,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,9448,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,9449,0)
 ;;=115.02^^63^613^44
 ;;^UTILITY(U,$J,358.3,9449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9449,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,9449,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,9449,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,9450,0)
 ;;=190.5^^63^613^58
 ;;^UTILITY(U,$J,358.3,9450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9450,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,9450,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,9450,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,9451,0)
 ;;=198.4^^63^613^59
 ;;^UTILITY(U,$J,358.3,9451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9451,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,9451,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,9451,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,9452,0)
 ;;=200.00^^63^613^81
 ;;^UTILITY(U,$J,358.3,9452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9452,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,9452,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,9452,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,9453,0)
 ;;=228.03^^63^613^38
 ;;^UTILITY(U,$J,358.3,9453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9453,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,9453,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,9453,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,9454,0)
 ;;=228.09^^63^613^39
 ;;^UTILITY(U,$J,358.3,9454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9454,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,9454,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,9454,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,9455,0)
 ;;=360.00^^63^613^73
 ;;^UTILITY(U,$J,358.3,9455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9455,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,9455,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,9455,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,9456,0)
 ;;=360.03^^63^613^21
 ;;^UTILITY(U,$J,358.3,9456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9456,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,9456,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,9456,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,9457,0)
 ;;=361.02^^63^613^76
 ;;^UTILITY(U,$J,358.3,9457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9457,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,9457,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,9457,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,9458,0)
 ;;=361.03^^63^613^75
 ;;^UTILITY(U,$J,358.3,9458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9458,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,9458,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,9458,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,9459,0)
 ;;=361.04^^63^613^79
 ;;^UTILITY(U,$J,358.3,9459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9459,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
